Paul Anderson, PhD, has over 35 years of experience in human health and ecological risk assessment. Since 2000, Anderson has led research on the presence and effects of pharmaceuticals and personal care products in surface water. His research began with the development of a screening level model that predicts the concentration of human pharmaceuticals and other compounds released from wastewater treatment plants in surface water across the United States. He helped develop a database that summarizes peer-reviewed literature on aquatic toxicity, environmental fate in surface water, and treatment plant removal of pharmaceuticals.
Anderson has an MA and PhD in Biology from Harvard University and a BA in Biology from Boston University.